Secreted Phospholipases A(2) from Animal Venoms in Pain and Analgesia

Autor(es)

Zambelli, Vanessa O. ^[1] ; Picolo, Gisele ^[1] ; Fernandes, Carlos A. H. ^[2] ; Fontes, Marcos R. M. ^[2] ; Cury, Yara ^[1]

Afiliação do(s) autor(es)

^[1] Butantan Inst, Lab Pain & Signaling, Ave Vital Brasil 1500, BR-05503900 Sao Paulo, SP - Brazil

^[2] Sao Paulo State Univ UNESP, Dept Phys & Biophys, Rua Prof Doutor Antonio Celso Wagner Zanin S-N, BR-18618689 Botucatu, SP - Brazil

• Tipo de documento: Artigo de Revisão
• Fonte: TOXINS; v. 9, n. 12 DEC 2017.
• Citações Web of Science: 10

Resumo

Animal venoms comprise a complex mixture of components that affect several biological systems. Based on the high selectivity for their molecular targets, these components are also a rich source of potential therapeutic agents. Among the main components of animal venoms are the secreted phospholipases A(2) (sPLA(2)s). These PLA(2) belong to distinct PLA(2)s groups. For example, snake venom sPLA(2)s from Elapidae and Viperidae families, the most important families when considering envenomation, belong, respectively, to the IA and IIA/IIB groups, whereas bee venom PLA(2) belongs to group III of sPLA(2)s. It is well known that PLA(2), due to its hydrolytic activity on phospholipids, takes part in many pathophysiological processes, including inflammation and pain. Therefore, secreted PLA(2)s obtained from animal venoms have been widely used as tools to (a) modulate inflammation and pain, uncovering molecular targets that are implicated in the control of inflammatory (including painful) and neurodegenerative diseases; (b) shed light on the pathophysiology of inflammation and pain observed in human envenomation by poisonous animals; and, (c) characterize molecular mechanisms involved in inflammatory diseases. The present review summarizes the knowledge on the nociceptive and antinociceptive actions of sPLA(2)s from animal venoms, particularly snake venoms. (AU)

• Processo FAPESP: 13/07467-1 - CeTICS - Centro de Toxinas, Imuno-Resposta e Sinalização Celular
• Beneficiário: Hugo Aguirre Armelin
• Modalidade de apoio: Auxílio à Pesquisa - Centros de Pesquisa, Inovação e Difusão - CEPIDs
• Processo FAPESP: 15/01254-1 - Avaliação do efeito da crotoxina conjugada à sílica nanoestruturada SBA-15 na dor crônica: aspectos imunomodulatórios, antiinflamatórios e antinociceptivos
• Beneficiário: Gisele Picolo
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 11/17974-2 - Avaliação do efeito da crotoxina na dor e nos sinais clínicos de animais portadores de encefalomielite autoimune experimental, um modelo animal de esclerose múltipla
• Beneficiário: Gisele Picolo
• Modalidade de apoio: Auxílio à Pesquisa - Regular